Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Lonafarnib |
Synonyms | |
Therapy Description |
Lonafarnib (SCH66336) is a farnesyl transferase inhibitor, which alters post-translational modification and activation of Ras proteins (PMID: 25323927, PMID: 29285232). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Lonafarnib | Sarasar | SCH66336 | Farnesyltransferase Inhibitor 4 | Lonafarnib (SCH66336) is a farnesyl transferase inhibitor, which alters post-translational modification and activation of Ras proteins (PMID: 25323927, PMID: 29285232). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|